How to buy ChromaDex Corporation stock | $6.38

ChromaDex Corporation is a biotechnology business based in the US. ChromaDex Corporation shares (CDXC) are listed on the NASDAQ and all prices are listed in US Dollars. ChromaDex Corporation employs 110 staff and has a trailing 12-month revenue of around 0.00.

ChromaDex Corporation stock price (NASDAQ: CDXC)

Use our graph to track the performance of CDXC stocks over time.

ChromaDex Corporation shares at a glance

• Key figures

Information last updated 2021-10-17.

Latest market close	$6.38
52-week range	$4.36 - $16.82
50-day moving average	$6.90
200-day moving average	$8.31
Wall St. target price	$14.80
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.36

Buy ChromaDex Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy ChromaDex Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ChromaDex Corporation price performance over time

Historical closes compared with the close of $6.38 from 2021-10-22

1 week (2021-10-18)	8.87%
1 month (2021-09-24)	-1.09%
3 months (2021-07-23)	-32.27%
6 months (2021-04-23)	-21.72%

1 year (2020-10-23)	32.37%
2 years (2019-10-25)	94.51%
3 years (2018-10-25)	80.23%
5 years (2016-10-25)	120.00%

ChromaDex Corporation financials

Revenue TTM	$62 million
Gross profit TTM	$35.3 million
Return on assets TTM	-28.28%
Return on equity TTM	-73%
Profit margin	-37.51%
Book value	$0.62
Market capitalisation	$433.7 million

TTM: trailing 12 months

Shorting ChromaDex Corporation shares

There are currently 3.5 million ChromaDex Corporation shares held short by investors – that's known as ChromaDex Corporation's "short interest". This figure is 4.9% down from 3.6 million last month.

There are a few different ways that this level of interest in shorting ChromaDex Corporation shares can be evaluated.

ChromaDex Corporation's "short interest ratio" (SIR)

ChromaDex Corporation's "short interest ratio" (SIR) is the quantity of ChromaDex Corporation shares currently shorted divided by the average quantity of ChromaDex Corporation shares traded daily (recently around 559829.28802589). ChromaDex Corporation's SIR currently stands at 6.18. In other words for every 100,000 ChromaDex Corporation shares traded daily on the market, roughly 6180 shares are currently held short.

However ChromaDex Corporation's short interest can also be evaluated against the total number of ChromaDex Corporation shares, or, against the total number of tradable ChromaDex Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ChromaDex Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 ChromaDex Corporation shares in existence, roughly 50 shares are currently held short) or 0.0829% of the tradable shares (for every 100,000 tradable ChromaDex Corporation shares, roughly 83 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ChromaDex Corporation.

Find out more about how you can short ChromaDex Corporation stock.

ChromaDex Corporation share dividends

We're not expecting ChromaDex Corporation to pay a dividend over the next 12 months.

Have ChromaDex Corporation's shares ever split?

ChromaDex Corporation's shares were split on a 1:3 basis on 12 April 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ChromaDex Corporation shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for ChromaDex Corporation shares which in turn could have impacted ChromaDex Corporation's share price.

ChromaDex Corporation share price volatility

Over the last 12 months, ChromaDex Corporation's shares have ranged in value from as little as $4.36 up to $16.82. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ChromaDex Corporation's is 1.7339. This would suggest that ChromaDex Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ChromaDex Corporation overview

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety ecommerce platform TRUNIAGEN. com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States.

Frequently asked questions

What percentage of ChromaDex Corporation is owned by insiders or institutions?
Currently 33.556% of ChromaDex Corporation shares are held by insiders and 30.241% by institutions. How many people work for ChromaDex Corporation?
Latest data suggests 110 work at ChromaDex Corporation. When does the fiscal year end for ChromaDex Corporation?
ChromaDex Corporation's fiscal year ends in December. Where is ChromaDex Corporation based?
ChromaDex Corporation's address is: 10900 Wilshire Boulevard, Los Angeles, CA, United States, 90024 What is ChromaDex Corporation's ISIN number?
ChromaDex Corporation's international securities identification number is: US1710774076 What is ChromaDex Corporation's CUSIP number?
ChromaDex Corporation's Committee on Uniform Securities Identification Procedures number is: 001627108